Developments Codexis enters agreement with drug innovator to create stereo-defined siRNA Codexis (NASDAQ: CDXS) has announced an agreement with a pioneering siRNA drug innovator to explore stereo-defined fragment synthesis using its ECO Synthesis Manufacturing Platform. According to Codexis, the agreement... September 28, 2026